Clinical Trial Update: To Compare the Pharmacokinetics of Budesonide Delivered by BDA MDI to Budesonide Delivered by Pulmicort Respules in Children With Asthma Aged 4 to 8 Years. [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic trial comparing budesonide delivered by BDA Metered Dose Inhaler to Pulmicort Respules in children aged 4 to 8 with asthma; completed wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Budesonide delivered by BDA MDI (budesonide)
• Pulmicort Respules (budesonide)

Snippet

Sponsor: Bond Avillion 2 Development LP | Conditions: Asthma | Phase 1 | Status: COMPLETED | Results posted: 2022-04-07